Paper340330
Cimetidine in the treatment of duodenal ulcer: review and commentary.
Winship DH. Gastroenterology, 1978. Cited by 150 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cimetidine in the treatment of duodenal ulcer: review and commentary. Papers, record 340330. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/340330
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Duodenal Ulcer | Major topic |
| Guanidines | Major topic |
| Antacids | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,305,288 | 4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/36305288 | PubMed |
| 21,253,147 | Approach to dyspepsia. | Can Fam Physician | 1988 | https://conductscience.org/library/papers/21253147 | PubMed |
| 7,460,717 | Are gastric and duodenal ulcers separate diseases or do they form a continuum? | Dig Dis Sci | 1981 | https://conductscience.org/library/papers/7460717 | PubMed |
| 7,410,042 | Cimetidine and duodenal ulcer: a study of initial and low dosage maintenance treatment in Ireland. | Ir J Med Sci | 1980 | https://conductscience.org/library/papers/7410042 | PubMed |
| 7,356,903 | Effect of cimetidine on the absorption of orally administered tetracycline. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7356903 | PubMed |
| 7,318,881 | Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7318881 | PubMed |
| 7,248,867 | Use of cimetidine in hospital patients. | Can Med Assoc J | 1981 | https://conductscience.org/library/papers/7248867 | PubMed |
| 7,215,949 | Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment. | Gut | 1981 | https://conductscience.org/library/papers/7215949 | PubMed |
| 6,986,242 | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/6986242 | PubMed |
| 6,984,638 | Immunological studies in patients with alopecia receiving dinitrochlorobenzene and cimetidine therapy. | Arch Dermatol Res | 1982 | https://conductscience.org/library/papers/6984638 | PubMed |
| 6,397,982 | Histidine decarboxylase inhibition: a novel approach towards the development of an effective and safe gastric anti-ulcer drug. | Agents Actions | 1984 | https://conductscience.org/library/papers/6397982 | PubMed |
| 6,376,292 | Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. | Gut | 1984 | https://conductscience.org/library/papers/6376292 | PubMed |
| 6,363,220 | Treatment of duodenal ulcer with pirenzepine and cimetidine. | Gut | 1984 | https://conductscience.org/library/papers/6363220 | PubMed |
| 6,130,952 | Clinical pharmacology of etintidine in patients with duodenal ulcer. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6130952 | PubMed |
| 6,107,261 | Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide. | Gut | 1980 | https://conductscience.org/library/papers/6107261 | PubMed |
| 6,106,545 | Current therapy in peptic ulcer. | Drugs | 1980 | https://conductscience.org/library/papers/6106545 | PubMed |
| 4,079,280 | Factors predicting the therapeutic outcome of duodenal ulcer treatment with H2-receptor antagonists. | Klin Wochenschr | 1985 | https://conductscience.org/library/papers/4079280 | PubMed |
| 3,967,563 | Healing of cysteamine-induced duodenal ulcers in the rat. | Dig Dis Sci | 1985 | https://conductscience.org/library/papers/3967563 | PubMed |
| 3,143,696 | pH-dependent degradation of nitrosocimetidine and its mechanisms. | Jpn J Cancer Res | 1988 | https://conductscience.org/library/papers/3143696 | PubMed |
| 1,685,465 | Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. | Gut | 1991 | https://conductscience.org/library/papers/1685465 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HRH2 | 3,274 | PubTator's text mining | https://conductscience.org/library/genes/3274 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/340330
GET https://conductscience.org/api/papers/v1/340330/cited_by?page=2